High Phosphate-Binding Capacity of Oxylanthanum Carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate Binders

BACKGROUND: A key focus for chronic kidney disease management is phosphate control, but currently available binders have suboptimal phosphate-binding capacity, and their characteristics result in low adherence and poor phosphate regulation. Oxylanthanum carbonate, a novel compound that uses propriet...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprague, Stuart M., Reddy, Guru, Jermasek, Douglas, Gupta, Pramod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Laboratory Investigation: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614253/
https://www.ncbi.nlm.nih.gov/pubmed/37231835
http://dx.doi.org/10.1159/000530989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614253/
https://www.ncbi.nlm.nih.gov/pubmed/37231835
http://dx.doi.org/10.1159/000530989

Ejemplares similares